Arkolith/Insider Trading/FREQ/Form 4

Lucchino David L.

President and CEO, DirectorFrequency Therapeutics, Inc. (FREQ) · full profile →Form 4 · filed Aug 2, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2023Sell(S)3K$0.49$1K673K
Jul 31, 2023Sell(S)3K$0.50$1K675K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-23-021846) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML